「pharmaceutically」を含む例文一覧(1482)

1 2 3 4 5 6 7 8 9 10 11 .... 29 30 次へ>
  • METHOD FOR EVALUATING PHARMACEUTICALLY ACTIVE SAPONIN AND PHARMACEUTICALLY ACTIVE SAPONIN
    薬理活性サポニンの評価方法および薬理活性サポニン - 特許庁
  • PHARMACEUTICALLY ACTIVE PYRROLIDINE DERIVATIVE
    医薬として活性なピロリジン誘導体 - 特許庁
  • PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVE
    医薬として活性なスルホンアミド誘導体 - 特許庁
  • PHARMACEUTICALLY ACTIVE SULFONYL AMINO ACID DERIVATIVE
    薬剤活性のあるスルホニルアミノ酸誘導体 - 特許庁
  • PREPARATION OF PHARMACEUTICALLY ACTIVE PARTICLE
    薬剤的に活性な粒子の調製方法 - 特許庁
  • PHARMACEUTICALLY ACTIVE COMPOUND AND METHOD OF USE THEREOF
    薬学的に活性の化合物及びその利用法 - 特許庁
  • To provide a new pharmaceutically active azole derivative.
    薬剤的に活性な新規アゾール誘導体の提供。 - 特許庁
  • The invention provides compounds of formula I and pharmaceutically acceptable salts thereof, pharmaceutically acceptable compositions containing the compounds and a method of treating various protein kinase-mediated disorders by using those compounds and compositions.
    本発明は、式(I)の化合物またはそれらの薬学的に受容可能な塩を提供する。 - 特許庁
  • The compound represented by formula (I), a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable ester thereof is provided.
    下記式(I)で表される化合物、その医薬的に許容される塩又はその医薬的に許容されるエステル。 - 特許庁
  • QUINOLONE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT
    キノロン誘導体又はその製薬学的に許容される塩 - 特許庁
  • To provide a new pharmaceutically active pyrrolidine derivative.
    医薬として活性な新規ピロリジン誘導体の提供。 - 特許庁
  • METHOD TO ADD PHARMACEUTICALLY ACTIVE COMPOUND TO SUBSTRATE
    薬学的に活性な化合物を基質に加える方法 - 特許庁
  • The vaccine also contains a pharmaceutically acceptable carrier.
    本ワクチンは薬学的に許容しうる担体も含有する。 - 特許庁
  • BENZENE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT
    ベンゼン誘導体またはその医薬的に許容される塩 - 特許庁
  • PHTHALIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME
    フタリド誘導体またはその薬学的に許容される塩 - 特許庁
  • There is provided a compound represented by formula, a pharmaceutically acceptable acid or a pharmaceutically acceptable complex thereof.
    式:の化合物、製薬学的に許容され得る酸とのその塩または製薬学的に許容され得るそれらの錯体。 - 特許庁
  • The compound is represented by formula (I) or a pharmaceutically acceptable salts thereof.
    式(I):の化合物又はその医薬的に許容される塩。 - 特許庁
  • CONJUGATES OF MEMBRANE TRANSLOCATING AGENT AND PHARMACEUTICALLY ACTIVE INGREDIENT
    膜転位剤および製薬学的有効成分の複合物 - 特許庁
  • The composition is provided by further containing a pharmaceutically acceptable excipient.
    薬学的に許容される賦形剤をさらに含む組成物。 - 特許庁
  • There is provided a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    式(I)の化合物又はその薬学的に許容しうる塩。 - 特許庁
  • The GPCR agonists are compounds of formula (I): or pharmaceutically acceptable salts thereof.
    式(I)の化合物:(I)またはその医薬的に許容される塩。 - 特許庁
  • The invention further relates to a pharmaceutical formulation containing the organic compound, its pharmaceutically acceptable salt and a pharmaceutically acceptable carrier.
    薬学的処方物は、この有機化合物、これらの薬学的に受容可能な塩および薬学的に受容可能なキャリアを含む。 - 特許庁
  • The liquid formulation composition contains rapamycin in a pharmaceutically effective dosage, a pharmaceutically acceptable solubility enhancer and a stabilizer.
    有効量のラパマイシン及び薬剤として許容可能な溶解度向上剤及び安定化剤を含有する液体配合組成物。 - 特許庁
  • The pharmaceutical composition comprises a compound represented by formula (Ia) or (Ib) or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable carrier.
    式(Ia)または(Ib)により表わされる化合物、あるいはそれらの薬学的に受容可能な塩または溶媒和物:。 - 特許庁
  • The pharmaceutical composition contains the compound represented by formula (I), an enantiomer thereof, and an additional salt thereof with a pharmaceutically acceptable base, in combination with one or more pharmaceutically acceptable vehicle.
    下記式( I )で表される化合物、その鏡像異性体、および薬学的に許容される塩基とその付加塩を提供する。 - 特許庁
  • A compound of general formula (I) and a pharmaceutically compatible salt thereof are disclosed.
    一般式(I)の化合物、およびその薬学的に適合する塩。 - 特許庁
  • There is provided the compound represented by formula (1), or a pharmaceutically acceptable salt thereof.
    下記式(1)の化合物、又はその薬学的に許容し得る塩。 - 特許庁
  • FAST DISSOLVING ORALLY CONSUMABLE FILM CONTAINING PHARMACEUTICALLY ACTIVE AGENT
    医薬活性剤を含有する速溶解性口腔消耗性フィルム - 特許庁
  • To obtain the subject composition capable of topically supplying a pharmaceutically active agent to the body of a person or animal by mixing the pharmaceutically active agent with a silicone rubber and a pharmaceutical vehicle in a specific ratio.
    ヒトまたは動物の体部へ局所的に薬学的活性剤を供給するために有用な組成物を提供する。 - 特許庁
  • CAPSULE FORMULATION OF PIRFENIDONE AND PHARMACEUTICALLY ACCEPTABLE EXCIPIENT
    ピルフェニドンおよび薬学的に受容可能な賦形剤のカプセル処方物 - 特許庁
  • IMPROVED EXTRACTION OF PHARMACEUTICALLY ACTIVE COMPONENT FROM PLANT MATERIAL
    植物材料からの薬学的に活性な成分の抽出の改良 - 特許庁
  • This intraocular pressure lowering composition for local administration contains an angiotensin II antagonist, boric acid or its pharmaceutically equivalent compound, ethylenediaminetetraacetic acid or its pharmaceutically equivalent compound, and a surfactant.
    アンジオテンシンII拮抗剤、ホウ酸類、エチレンジアミン四酢酸類及び界面活性剤を含有する局所投与用眼圧低下組成物。 - 特許庁
  • To provide N-substituted hydromorphones or pharmaceutically acceptable salts thereof.
    N−置換ヒドロモルホン又はその医薬的に許容可能な塩の提供。 - 特許庁
  • A compound containing a structure represented by the formula or its pharmaceutically acceptable salt is provided.
    下式を有する化合物又はその薬学的に許容し得る塩。 - 特許庁
  • IMPROVED METHOD FOR PURIFYING AND PHARMACEUTICALLY PREPARING ORTHO-PHTHALALDEHYDE
    o−フタルアルデヒドを精製及び製剤化するための改善された方法 - 特許庁
  • To provide a clinically satisfiable sustained-release pharmaceutical composition for pharmaceutically active ionic substances, whether the pharmaceutically active substances is water-soluble or not.
    医薬活性物質の水溶性のいかんに拘わらず、臨床上満足できるイオン性医薬活性物質の徐放性製剤を提供する。 - 特許庁
  • An example of the pharmaceutically acceptable salt of the pilocarpine is pilocarpine hydrochloride.
    ピロカルピンの薬理的に許容される塩の例は、塩酸ピロカルピンである。 - 特許庁
  • The quinazoline derivative represented by formula (I) or the pharmaceutically acceptable salt thereof is provided.
    式(I)のキナゾリン誘導体:又は医薬的に受容可能なその塩。 - 特許庁
  • The pharmaceutical composition comprises a compound represented by formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient.
    式(I)で示される化合物またはその医薬上許容される塩及び医薬上許容される担体又は賦形剤を含む医薬組成物。 - 特許庁
  • This composition for rhinitis is characterized by containing emedastine or its pharmaceutically permissible salt and glycyrrhizinic acid or its pharmaceutically permissible salt.
    エメダスチンまたはその薬学的に許容される塩、および、グリチルリチン酸またはその薬学的に許容される塩を含有することを特徴とする。 - 特許庁
  • The compound expressed by formula (III) and its pharmaceutically acceptable salts are disclosed.
    式(III)で示される化合物並びにその医薬的に許容可能な塩。 - 特許庁
  • MEDICAL APPLICATION OF INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    インドール誘導体、またはその薬理学的に許容される塩の医薬用途 - 特許庁
  • The composition further contains a pharmaceutically acceptable delivery carrier.
    この組成物はさらに、薬剤的に許容可能な送達(delivery)担体から成る。 - 特許庁
  • The compound represented by general formula (I) and pharmaceutically acceptable salt thereof are provided.
    下記一般式(I)を有する化合物又はその薬理上許容される塩: - 特許庁
  • INJECTION MOLDING PROCESS FOR PREPARATION OF ORAL DELIVERY DEVICE OF PHARMACEUTICALLY ACTIVE AGENT
    医薬活性剤の経口デリバリーデバイスの調製のための射出成形法 - 特許庁
  • There are provided the compounds represented by a formula (B531) in Fig. or pharmaceutically acceptable salts thereof.
    下記式で表される化合物又はその医薬的に受容可能な塩。 - 特許庁
  • The present invention provides a drug composition used as an anticancer drug which contains a 4, 8-dihydrobenzodithiophene-4, 8-dione derivative represented by Formula (D) or (E) of an effective amount as an anticancer drug or its salt acceptable pharmaceutically and a pharmaceutically acceptable carrier.
    下記式(D)または下記式(E)で示される4,8−ジヒドロベンゾジチオフェン−4,8−ジオンの誘導体またはその製薬上許容できる塩。 - 特許庁
  • Pharmaceutical compositions containing an effective amount of the compound described in formula (I) or its pharmaceutically acceptable salts and pharmaceutically acceptable carriers are also included therein.
    および、有効量の式(I)に記載の化合物またはその薬学的に受容可能な塩と、薬学的に受容可能なキャリアとを含有する、医薬組成物。 - 特許庁
  • To provide a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound; and at least one chewable pharmaceutically acceptable excipient.
    薬学的に有効量のランタン化合物;および少なくとも1つの咀嚼型薬学的に許容し得る賦型剤を含む咀嚼型ランタン製剤の提供。 - 特許庁
  • This compound is represented by the formula (1) and a pharmaceutically acceptable salt thereof.
    式1: の化合物及びその製薬学的に許容しうる塩に関する。 - 特許庁
1 2 3 4 5 6 7 8 9 10 11 .... 29 30 次へ>

例文データの著作権について

  • 特許庁
    Copyright © Japan Patent office. All Rights Reserved.